Not a drug, food, cosmetic, dietary supplement, or medical device
Huang T, Wang J, et al
After starting and after each dose increase, tirzepatide can cut the peak absorption of an oral contraceptive by more than half, so the label guidance is a non-oral method or added barrier protection for four weeks after starting and four weeks after each increase. It is a first-dose-and-escalation effect, not a permanent block on all oral drugs
Beyond-use periods must follow the SmPC : Generic claims about multi-dose vials remaining usable for a fixed number of days are not appropriate
Key Features Of Lipo-MIC & B12 Injections: Advanced Formula: Contains a synergistic blend of Methionine, Inositol, Choline (MIC), and high-quality vitamin B12, all known for their roles in fat metabolism and energy production
Formulations are not standardised concentrations vary by compounding pharmacy, which is one reason cross-clinic comparisons and published timelines are unreliable